Treatment of Indolent and Advanced Systemic Mastocytosis
Castells M, Butterfield J
J Allergy Clin Immunol Pract · 2022
Key Findings
- ●Stepwise treatment: H1/H2 antihistamines, cromolyn, leukotriene antagonists, then cytoreductive therapy
- ●Anaphylaxis prevention paramount in ISM management
Referenced in (1 disease)
Validation history
Full log →- passsource metadataJun 1, 2026, 04:40 PMby pubmed-api
Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).
tools: pubmed.esummary, crossref.works
ID: pmid-35615325DOI: 10.4084/MJHID.2022.040PMID: 35615325